Efficacy and tolerability of infliximab retreatment in patients with inflammatory bowel disease: a systematic review and meta-analysis

BACKGROUND: A large proportion of patients with inflammatory bowel disease (IBD) relapse after drug discontinuation despite achieving a stable state of infliximab-induced clinical remission. Resuming the use of the same tumor necrosis factor-alpha (TNF-α) inhibitors in patients who relapse following...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Seungwon, Yang, Siyoung, Kwon Jo, Young, Kim, Seungyeon, Jung Chang, Min, Choi, Junjeong, Hee Cheon, Jae, Yu, Yun Mi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438941/
https://www.ncbi.nlm.nih.gov/pubmed/34729142
http://dx.doi.org/10.1177/20406223211041927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438941/
https://www.ncbi.nlm.nih.gov/pubmed/34729142
http://dx.doi.org/10.1177/20406223211041927

Ejemplares similares